Aerosol drug delivery to the lungs during nasal high flow therapy: an in vitro study

Aerosol drug delivery to the lungs during nasal high flow therapy: an in vitro study

Abstract Background Aerosol delivery through a nasal high flow (NHF) system is attractive for clinicians as it allows for simultaneous administration of oxygen and inhalable drugs. However, delivering a fine particle fraction (FPF, particle wt. fraction < 5.0 μm) of drugs into the lungs has been...

Full description

Bibliographic Details
Main Authors: Martin Wallin, Patricia Tang, Rachel Yoon Kyung Chang, Mingshi Yang, Warren H. Finlay, Hak-Kim Chan
Format: Article
Language:English
Published: BMC 2019-02-01
Series:BMC Pulmonary Medicine
Subjects:
Aerosol
Powders
Inhalable drugs
Nasal cannula
Pulmonary disease, chronic obstructive
Lungs
Online Access:http://link.springer.com/article/10.1186/s12890-019-0807-9

Internet

http://link.springer.com/article/10.1186/s12890-019-0807-9

Similar Items